Parkinson’s disease (PD) is a neurological condition that affects millions of people worldwide. There is currently no cure for PD, but focused ultrasound – a noninvasive, revolutionary technology – is now FDA approved to address the symptoms, including tremors, rigidity, and dyskinesia. Researchers are also investigating focused ultrasound’s ability to assist with PD diagnosis and monitor disease progression.
To commemorate Parkinson’s Awareness Month, the Foundation hosted a webinar on the topic. A panel of experts provided a comprehensive overview of the current state of PD treatment options, including the latest advancements in focused ultrasound. The webinar also covered the status of insurance reimbursement for the treatment.
Rebecca Gilbert, MD, PhD
Senior Vice President and Chief Scientific Officer
American Parkinson Disease Association
Paul Fishman, MD, PhD
Clinical Professor of Neurology
University of Maryland School of Medicine
Michael Broad, PhD
Data Strategy Director
Focused Ultrasound Foundation